These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29217476)

  • 1. SUMO1 impact on Alzheimer disease pathology in an amyloid-depositing mouse model.
    Knock E; Matsuzaki S; Takamura H; Satoh K; Rooke G; Han K; Zhang H; Staniszewski A; Katayama T; Arancio O; Fraser PE
    Neurobiol Dis; 2018 Feb; 110():154-165. PubMed ID: 29217476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer's disease senile plaques and neuritic dystrophy in APP/PS1 transgenic mice].
    Zhao XY; Wang DD; Shan Y; Zhu CQ
    Sheng Li Xue Bao; 2013 Jun; 65(3):253-62. PubMed ID: 23788181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO1 modulates Aβ generation via BACE1 accumulation.
    Yun SM; Cho SJ; Song JC; Song SY; Jo SA; Jo C; Yoon K; Tanzi RE; Choi EJ; Koh YH
    Neurobiol Aging; 2013 Mar; 34(3):650-62. PubMed ID: 22975420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO1 promotes Aβ production via the modulation of autophagy.
    Cho SJ; Yun SM; Jo C; Lee DH; Choi KJ; Song JC; Park SI; Kim YJ; Koh YH
    Autophagy; 2015; 11(1):100-12. PubMed ID: 25484073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
    Chenfei Z; Haizhen Y; Jie X; Na Z; Bo X
    Neurosci Lett; 2022 Jan; 767():136303. PubMed ID: 34695453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.
    Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ
    Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins.
    Dorval V; Mazzella MJ; Mathews PM; Hay RT; Fraser PE
    Biochem J; 2007 Jun; 404(2):309-16. PubMed ID: 17346237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques.
    Hashimoto T; Fujii D; Naka Y; Kashiwagi-Hakozaki M; Matsuo Y; Matsuura Y; Wakabayashi T; Iwatsubo T
    Acta Neuropathol Commun; 2020 Dec; 8(1):212. PubMed ID: 33287899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
    Kim TK; Han HE; Kim H; Lee JE; Choi D; Park WJ; Han PL
    Exp Mol Med; 2012 Dec; 44(12):740-8. PubMed ID: 23172351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.
    Melnikova T; Fromholt S; Kim H; Lee D; Xu G; Price A; Moore BD; Golde TE; Felsenstein KM; Savonenko A; Borchelt DR
    J Neurosci; 2013 Feb; 33(9):3765-79. PubMed ID: 23447589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model.
    Verheijen BM; Stevens JAA; Gentier RJG; van 't Hekke CD; van den Hove DLA; Hermes DJHP; Steinbusch HWM; Ruijter JM; Grimm MOW; Haupenthal VJ; Annaert W; Hartmann T; van Leeuwen FW
    Neurobiol Aging; 2018 Dec; 72():62-71. PubMed ID: 30216939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO1-conjugation is altered during normal aging but not by increased amyloid burden.
    Stankova T; Piepkorn L; Bayer TA; Jahn O; Tirard M
    Aging Cell; 2018 Aug; 17(4):e12760. PubMed ID: 29633471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
    Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
    Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.